GLP1R and diabetic retinopathy: Lin et al demonstrated the rate of developing diabetic retinopathy was comparable between individuals receiving SGLT2i and GLP1-ra, although individuals receiving SGLT2i had a lower risk of proliferative diabetic retinopathy [14].